Formosa and Medvisis agree on post-operative eye pain therapy
Formosa has signed an exclusive licensing agreement with Medvisis for APP13007 for post-operative inflammation and pain after ocular surgery.
Formosa has signed an exclusive licensing agreement with Medvisis for APP13007 for post-operative inflammation and pain after ocular surgery.
What's Your Reaction?
